• Neurological associations of COVID-19 

  Ellul, Mark A. et al. (2020-07-02)

  Background: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with ...
• Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19 

  Funck-Brentano, Christian; Nguyen, Lee S.; Salem, Joe-Elie (2020-07-09)

  A recent Lancet Article by Mandeep Mehra and colleagues, which reported adverse events associated with hydroxychloroquine or chloroquine treatment in patients with COVID-19, has been retracted by three of the authors, along ...
• Systematic review of artificial intelligence techniques in the detection and classification of COVID-19 medical images in terms of evaluation and benchmarking: Taxonomy analysis, challenges, future solutions and methodological aspects 

  Albahri, O.S. et al. (2020-07-01)

  This study presents a systematic review of artificial intelligence (AI) techniques used in the detection and classification of coronavirus disease 2019 (COVID-19) medical images in terms of evaluation and benchmarking. ...
• Hydroxychloroquine safety: A meta-analysis of randomized controlled trials 

  Eljaaly, Khalid et al. (2020-07-06)

  Background: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. We conducted this meta-analysis to compare the safety of HCQ versus ...
• A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 

  Usman, Muhammad Shariq et al. (2020-06-02)

  The angiotensin converting enzyme (ACE) 2 is a cell surface protein used for entry into type II pneumocytes and other tissues by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the infective agent of COVID-19. ...
• Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis 

  Mehta, Hemalkumar B. et al. (2020-06-09)

  Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many initiatives to identify safe and efficacious treatments, yet little is known regarding where early efforts have focused. We aimed to characterise ...
• Extrapulmonary manifestations of COVID-19 

  Gupta, Aakriti et al. (2020-07-10)

  Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and ...
• A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting 

  Razonable, Raymund R. et al. (2020-05-30)

  The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which presents an unprecedented challenge to medical providers worldwide. Although most SARS-CoV-2–infected ...
• Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review 

  Seirafianpour, Farnoosh et al. (2020-07-08)

  Background: COVID‐19 had a great impact on medical approaches among dermatologist. Objective: This systematic review focuses on all skin problems related to COVID‐19, including primary and secondary COVID‐related cutaneous ...
• Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines 

  Pierre, Fontana et al. (2020-06-22)

  AIMS OF THE STUDY: Many centres have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia. The aims of this study were (1) to summarise the reported risk of ...
• Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis 

  Yu, Chengjun et al. (2020-06-25)

  Background: There is no vaccine or specific antiviral treatment for HCoVs infection. The use of type I interferons for coronavirus is still under great debate in clinical practice. Materials and methods: A literature search ...
• Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review 

  Wiersinga, W. Joost et al. (2020-07-10)

  [Abstract]. Importance The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden and substantial increase in hospitalizations ...
• Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review 

  Santos, Jennifer et al. (2020-06-30)

  The need for proven disease-specific treatments for the novel pandemic coronavirus SARS-CoV-2 necessitates a worldwide search for therapeutic options. Since the SARS-CoV-2 virus shares extensive homology with SARS-CoV and ...
• Interventions for people with disabilities in low‐and middle‐income countries: evidence and gap map 

  Evidence Aid (2020-07-16)

  Citation: Saran A, White H, Kuper H. Evidence and gap map of studies assessing the effectiveness of interventions for people with disabilities in low‐and middle‐income countries. Campbell Systematic Reviews. 2020;16(1):e1070. ...
• Chest CT and reverse transcriptase-polymerase chain reaction assays for diagnosing COVID-19 

  Evidence Aid (2020-07-16)

  Citation: Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology. 2020 Apr 17:201343. What is this? Various methods ...
• Genomewide Association Study of Severe Covid-19 with Respiratory Failure 

  Ellinghaus, David et al. (2020-06-17)

  BACKGROUND: There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). Genomewide ...
• Lopinavir-ritonavir for COVID-19: A living systematic review 

  Verdugo-Paiva, Francisca et al. (2020-07-15)

  Objective: Provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods: We conducted searches in the special L·OVE ...
• Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol 

  Dambha-Miller, Hajira et al. (2020-07-14)

  Background: The SARS-CoV-2 virus causing COVID-19 binds human angiotensin-converting enzyme 2 (ACE2) receptors in human tissues. ACE2 expression may be associated with COVID-19 infection and mortality rates. Routinely ...
• Systematic Review and Meta‐analysis of Effectiveness of Treatment Options Against SARS‐CoV‐2 infection 

  Chandrasekar, Viveksandeep Thoguluva et al. (2020-07-15)

  Treatment options for Severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐CoV‐2) are limited with no clarity on efficacy and safety profiles. We performed a systematic review and meta‐analysis of studies on ...
• Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-Analysis 

  Kashour, Zakariya Tarek et al. (2020-07-15)

  Background: The antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) show promising SARS-CoV-2 anti-viral activity in vitro; however, clinical studies have reported conflicting results. We sought to systematically ...

View more